Abbott Laboratories

詳細情報 Abbott Laboratories 企業名

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.

企業情報

企業コードABT

会社名Abbott Laboratories

上場日Mar 01, 1937

最高経営責任者「CEO」Mr. Robert B. Ford

従業員数114000

証券種類Ordinary Share

決算期末Mar 01

本社所在地100 Abbott Park Road

都市ABBOTT PARK

証券取引所NYSE Consolidated

国United States of America

郵便番号60064-3500

電話番号12246676100

ウェブサイトhttps://www.abbott.com

企業コードABT

上場日Mar 01, 1937

最高経営責任者「CEO」Mr. Robert B. Ford

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Daniel J. Starks

Independent Director

6.73M

+0.02%

Mr. Hubert L. Allen

Executive Vice President, General Counsel, Secretary

191.90K

+3.84%

Mr. Daniel Gesua Sive Salvadori

Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products

133.77K

+6.42%

Ms. Mary K. Moreland

Executive Vice President - Human Resources

95.58K

-0.82%

Ms. Lisa D. Earnhardt

Executive Vice President, Group President - Medical Devices

71.93K

--

Mr. Louis H. (Lou) Morrone

Executive Vice President - Core Diagnostics

66.61K

-0.40%

Mr. Philip P. Boudreau

Chief Financial Officer, Executive Vice President - Finance

51.36K

-9.75%

Dr. Robert J. Alpern, M.D.

Independent Director

40.80K

+4.17%

Ms. Nancy Mckinstry

Lead Independent Director

38.72K

+4.41%

Ms. Sally E. Blount, Ph.D.

Independent Director

34.06K

-2.76%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Daniel J. Starks

Independent Director

6.73M

+0.02%

Mr. Hubert L. Allen

Executive Vice President, General Counsel, Secretary

191.90K

+3.84%

Mr. Daniel Gesua Sive Salvadori

Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products

133.77K

+6.42%

Ms. Mary K. Moreland

Executive Vice President - Human Resources

95.58K

-0.82%

Ms. Lisa D. Earnhardt

Executive Vice President, Group President - Medical Devices

71.93K

--

Mr. Louis H. (Lou) Morrone

Executive Vice President - Core Diagnostics

66.61K

-0.40%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Diabetes Care

1.83B

17.64%

Core Laboratory

1.18B

11.36%

Adult Nutritionals

1.10B

10.67%

Pediatric Nutritionals

1.04B

10.05%

Key Emerging Markets

965.00M

9.32%

Other

4.24B

40.96%

地域別USD

会社名

収益

比率

All other Countries

6.19B

59.76%

United States

4.17B

40.24%

事業別

地域別

事業別USD

会社名

収益

比率

Diabetes Care

1.83B

17.64%

Core Laboratory

1.18B

11.36%

Adult Nutritionals

1.10B

10.67%

Pediatric Nutritionals

1.04B

10.05%

Key Emerging Markets

965.00M

9.32%

Other

4.24B

40.96%

株主

更新時刻: Fri, May 16

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

9.88%

BlackRock Institutional Trust Company, N.A.

5.09%

State Street Global Advisors (US)

4.46%

Capital International Investors

3.84%

Capital Research Global Investors

2.92%

Other

73.81%

株主統計

比率

The Vanguard Group, Inc.

9.88%

BlackRock Institutional Trust Company, N.A.

5.09%

State Street Global Advisors (US)

4.46%

Capital International Investors

3.84%

Capital Research Global Investors

2.92%

Other

73.81%

種類

株主統計

比率

Investment Advisor

46.24%

Investment Advisor/Hedge Fund

23.11%

Research Firm

3.66%

Pension Fund

2.33%

Bank and Trust

2.22%

Sovereign Wealth Fund

1.30%

Insurance Company

1.08%

Hedge Fund

0.53%

Individual Investor

0.48%

Other

19.04%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

4616

1.41B

81.28%

+6.94M

2025Q1

4644

1.42B

81.42%

+12.91M

2024Q4

4535

1.39B

80.22%

+15.89M

2024Q3

4391

1.36B

78.29%

-11.85M

2024Q2

4400

1.36B

78.24%

-7.03M

2024Q1

4402

1.35B

77.67%

-9.71M

2023Q4

4429

1.35B

77.56%

-11.05M

2023Q3

4298

1.34B

77.39%

-25.33M

2023Q2

4297

1.35B

77.60%

-13.55M

2023Q1

4281

1.35B

77.46%

-8.61M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

169.07M

9.72%

+1.18M

+0.70%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

87.82M

5.05%

+752.19K

+0.86%

Mar 31, 2025

State Street Global Advisors (US)

77.66M

4.46%

+497.07K

+0.64%

Mar 31, 2025

Capital International Investors

66.82M

3.84%

-1.15M

-1.69%

Mar 31, 2025

Capital Research Global Investors

50.73M

2.92%

-3.36M

-6.22%

Mar 31, 2025

Geode Capital Management, L.L.C.

36.90M

2.12%

+1.23M

+3.46%

Mar 31, 2025

Wellington Management Company, LLP

29.76M

1.71%

+3.37M

+12.77%

Mar 31, 2025

JP Morgan Asset Management

28.80M

1.66%

+3.67M

+14.58%

Mar 31, 2025

Norges Bank Investment Management (NBIM)

20.98M

1.21%

+626.72K

+3.08%

Dec 31, 2024

Wells Fargo Advisors

15.42M

0.89%

+165.54K

+1.09%

Mar 31, 2025

詳細を見る

関連ETF

更新時刻: Tue, Aug 5

銘柄名

比率

iShares U.S. Medical Devices ETF

18.83%

Goldman Sachs Future Health Care Equity ETF

5.52%

Proshares Ultra Health Care

4.84%

Health Care Select Sector SPDR Fund

4.83%

NYLI Healthy Hearts ETF

4.66%

iShares U.S. Healthcare ETF

4.65%

Invesco Pharmaceuticals ETF

4.64%

Polen Capital Global Growth ETF

4.64%

GMO US Quality ETF

4.5%

AdvisorShares Focused Equity ETF

4.47%

詳細を見る

iShares U.S. Medical Devices ETF

比率18.83%

Goldman Sachs Future Health Care Equity ETF

比率5.52%

Proshares Ultra Health Care

比率4.84%

Health Care Select Sector SPDR Fund

比率4.83%

NYLI Healthy Hearts ETF

比率4.66%

iShares U.S. Healthcare ETF

比率4.65%

Invesco Pharmaceuticals ETF

比率4.64%

Polen Capital Global Growth ETF

比率4.64%

GMO US Quality ETF

比率4.5%

AdvisorShares Focused Equity ETF

比率4.47%

配当金

過去5年間の配当金総支払額は 16.46B 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Dec 13, 2024

ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Feb 14, 2025 going ex on Jan 15, 2025 with reinvestment option

Jan 15, 2025

Feb 14, 2025

Jan 15, 2025

Sep 19, 2024

ABT.NB Final Cash Dividend of gross USD 0.55 paid on Nov 15, 2024 going ex on Oct 15, 2024

Oct 15, 2024

Nov 15, 2024

Oct 15, 2024

Jun 15, 2024

ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Aug 15, 2024 going ex on Jul 15, 2024 with reinvestment option

Jul 15, 2024

Aug 15, 2024

Jul 15, 2024

Feb 16, 2024

ABT.NB Interim Cash Dividend of gross USD 0.55 paid on May 15, 2024 going ex on Apr 12, 2024

Apr 15, 2024

May 15, 2024

Apr 12, 2024

Dec 15, 2023

ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Feb 15, 2024 going ex on Jan 11, 2024 with reinvestment option

Jan 12, 2024

Feb 15, 2024

Jan 11, 2024

Sep 21, 2023

ABT.NB Final Cash Dividend of gross USD 0.51 paid on Nov 15, 2023 going ex on Oct 12, 2023 with reinvestment option

Oct 13, 2023

Nov 15, 2023

Oct 12, 2023

Jun 09, 2023

ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 15, 2023 going ex on Jul 13, 2023 with reinvestment option

Jul 14, 2023

Aug 15, 2023

Jul 13, 2023

Feb 17, 2023

ABT.NB Interim Cash Dividend of gross USD 0.51 paid on May 15, 2023 going ex on Apr 13, 2023 with reinvestment option

Apr 14, 2023

May 15, 2023

Apr 13, 2023

Dec 09, 2022

ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 15, 2023 going ex on Jan 12, 2023 with reinvestment option

Jan 13, 2023

Feb 15, 2023

Jan 12, 2023

Sep 15, 2022

ABT.NB Final Cash Dividend of gross USD 0.47 paid on Nov 15, 2022 going ex on Oct 13, 2022 with reinvestment option

Oct 14, 2022

Nov 15, 2022

Oct 13, 2022

詳細を見る

株式分割

日付

種類

比率

データなし

日付

種類

比率

データなし

129.065USD

Abbott Laboratories

129.065

概要

企業名

金融